C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering

C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering

Source: 
Endpoints
snippet: 

On Friday, Massachusetts-based biotechs C4 Therapeutics and Oncorus became the latest to jump onto Nasdaq.